Cargando…
Use of REGEN-COV in children after heart transplantation for treatment and post-exposure prophylaxis of COVID-19
COVID-19 pandemic continues to evolve and new variants like Delta and Omicron have been discovered. REGEN-COV is a recombinant human monoclonal antibody to the spike protein of SARS-CoV-2 which received emergency use authorisation for treatment and post-exposure prophylaxis in patients with high ris...
Autores principales: | Gupta, Dipankar, Clifford, Stephanie A., Fricker, Frederick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304944/ https://www.ncbi.nlm.nih.gov/pubmed/35798332 http://dx.doi.org/10.1017/S1047951122002190 |
Ejemplares similares
-
Use of REGEN-COV in Pediatric Patients After Heart Transplantation for Treatment and Post-Exposure Prophylaxis of COVID-19
por: Clifford, S.A., et al.
Publicado: (2022) -
Risk factors associated with post-transplant superior caval vein stenosis in paediatric heart transplantation
por: Tadros, Hanna J., et al.
Publicado: (2021) -
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation
por: Marcacci, Gianpaolo, et al.
Publicado: (2022) -
Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018) -
Post-exposure prophylaxis to prevent varicella in immunocompromised children
por: Yamaguchi, Makoto, et al.
Publicado: (2022)